Roles of interferon regulatory factor 4 in the AKI-CKD transition, glomerular diseases and kidney allograft rejection.

AKI-CKD transition Interferon regulatory factor 4 glomerular disease kidney allograft rejection

Journal

Renal failure
ISSN: 1525-6049
Titre abrégé: Ren Fail
Pays: England
ID NLM: 8701128

Informations de publication

Date de publication:
2023
Historique:
medline: 28 9 2023
pubmed: 27 9 2023
entrez: 27 9 2023
Statut: ppublish

Résumé

Interferon regulatory factor 4 (IRF4) is expressed in immune cells and is a member of the interferon regulatory factor family. Recently, it has been found that IRF4 plays important roles in the acute kidney injury (AKI)-chronic kidney disease (CKD) transition, glomerular diseases and kidney allograft rejection. In particular, the relationship between IRF4 and the AKI-CKD transition has attracted widespread attention. Furthermore, it was also found that the deficiency of IRF4 hindered the transition from AKI to CKD through the suppression of macrophage-to-fibroblast conversion, inhibition of M1-M2 macrophage polarization, and reduction in neutrophil inward flow. Additionally, an examination of the crucial role of IRF4 in glomerular disease was conducted. It was reported that inhibiting IRF4 could alleviate the progression of glomerular disease, and potential physiopathology mechanisms associated with IRF4 were postulated. Lastly, IRF4 was found to have detrimental effects on the development of antibody-mediated rejection (ABMR) and T-cell-mediated rejection (TCMR).

Identifiants

pubmed: 37755331
doi: 10.1080/0886022X.2023.2259228
pmc: PMC10538460
doi:

Substances chimiques

Interferon Regulatory Factors 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2259228

Références

N Engl J Med. 2009 Jul 2;361(1):11-21
pubmed: 19571279
J Am Soc Nephrol. 2015 Jul;26(7):1503-12
pubmed: 25694468
N Engl J Med. 2015 Mar 12;372(11):1074-5
pubmed: 25760364
Front Immunol. 2022 Sep 08;13:978262
pubmed: 36159833
JCI Insight. 2019 Jan 24;4(2):
pubmed: 30674729
J Nephrol. 2015 Feb;28(1):51-8
pubmed: 24756968
Proc Natl Acad Sci U S A. 2012 May 29;109(22):8664-9
pubmed: 22552227
Int Immunopharmacol. 2021 Nov;100:108142
pubmed: 34555644
JCI Insight. 2022 Feb 22;7(4):
pubmed: 35025763
J Clin Med. 2020 Jul 10;9(7):
pubmed: 32664235
Kidney Int. 2011 Sep;80(5):545-52
pubmed: 21677634
N Engl J Med. 2011 Dec 1;365(22):2110-21
pubmed: 22129255
Lancet. 2010 Jun 12;375(9731):2073-81
pubmed: 20483451
Phytomedicine. 2019 Jun;59:152913
pubmed: 30991182
Proc Natl Acad Sci U S A. 2005 Nov 1;102(44):15989-94
pubmed: 16236719
Nature. 2009 Mar 19;458(7236):351-6
pubmed: 19182775
Nat Genet. 2014 Nov;46(11):1187-96
pubmed: 25305756
Clin J Am Soc Nephrol. 2023 Jan 1;18(1):60-71
pubmed: 36719159
Biochim Biophys Acta. 2013 Dec;1832(12):2232-43
pubmed: 23999007
J Transl Med. 2016 Apr 21;14:98
pubmed: 27098560
Nat Commun. 2015 Jun 01;6:7270
pubmed: 26028593
Immunity. 2010 Aug 27;33(2):192-202
pubmed: 20674401
J Am Soc Nephrol. 2020 Dec;31(12):2949-2963
pubmed: 32912934
Medicine (Baltimore). 2006 May;85(3):147-156
pubmed: 16721257
BMC Mol Cell Biol. 2020 Feb 3;21(1):4
pubmed: 32013860
Clin Chem. 2018 Sep;64(9):1361-1369
pubmed: 30012641
Proc Natl Acad Sci U S A. 2008 Dec 30;105(52):20846-51
pubmed: 19088203
Semin Nephrol. 2015 Sep;35(5):396-409
pubmed: 26573543
Nat Genet. 2011 Dec 25;44(2):178-82
pubmed: 22197929
Clin J Am Soc Nephrol. 2017 Apr 3;12(4):677-686
pubmed: 28159829
J Allergy Clin Immunol. 2009 Jun;123(6):1277-86.e5
pubmed: 19427685
Sci Rep. 2020 Feb 7;10(1):2122
pubmed: 32034190
Transpl Int. 2015 Feb;28(2):136-43
pubmed: 25205033
J Am Soc Nephrol. 2020 Oct;31(10):2457-2474
pubmed: 32723838
Eur J Immunol. 2011 Oct;41(10):3063-74
pubmed: 21728176
J Am Soc Nephrol. 2013 Nov;24(11):1743-54
pubmed: 23970121
Nat Commun. 2020 Mar 30;11(1):1600
pubmed: 32231244
Clin J Am Soc Nephrol. 2017 Jun 7;12(6):983-997
pubmed: 28550082
J Clin Invest. 2008 Feb;118(2):545-59
pubmed: 18188453
Int Immunopharmacol. 2019 Oct;75:105758
pubmed: 31377589
Biomed Pharmacother. 2019 Jul;115:108904
pubmed: 31060008
N Engl J Med. 2021 Aug 19;385(8):729-743
pubmed: 34407344
Mucosal Immunol. 2008 Nov;1 Suppl 1:S5-9
pubmed: 19079230
J Am Soc Nephrol. 2021 May 3;32(5):1037-1052
pubmed: 33619052
Nat Rev Nephrol. 2018 Oct;14(10):607-625
pubmed: 30135570
Kidney Int Rep. 2018 Aug 22;3(6):1424-1433
pubmed: 30450469
J Urol Nephrol (Paris). 1968 Sep;74(9):694-5
pubmed: 4180586
J Rheumatol. 2014 Oct;41(10):1998-2007
pubmed: 25225281
Nat Genet. 2011 Mar 13;43(4):321-7
pubmed: 21399633
Nat Immunol. 2007 Sep;8(9):958-66
pubmed: 17676043
Sci Rep. 2019 Dec 5;9(1):18445
pubmed: 31804508
Iran J Kidney Dis. 2021 May;15(3):222-228
pubmed: 33994382
Annu Rev Pathol. 2008;3:189-220
pubmed: 18039144
Science. 1997 Jan 24;275(5299):540-3
pubmed: 8999800
Clin J Am Soc Nephrol. 2009 May;4(5):891-8
pubmed: 19406959
Z Rheumatol. 2014 Aug;73(6):565-70
pubmed: 24292686
Front Immunol. 2019 Oct 01;10:2162
pubmed: 31632388
Semin Nephrol. 2004 May;24(3):179-96
pubmed: 15156525
Cell Discov. 2022 Mar 1;8(1):21
pubmed: 35228523
Nat Rev Drug Discov. 2008 May;7(5):411-25
pubmed: 18404150
J Am Soc Nephrol. 2010 Oct;21(10):1791-7
pubmed: 20595679
JCI Insight. 2021 Jun 22;6(12):
pubmed: 34032636
Kidney Int. 2013 Oct;84(4):745-55
pubmed: 23636175
J Am Soc Nephrol. 2008 Dec;19(12):2384-95
pubmed: 18776126
Transplantation. 1998 Jul 15;66(1):29-37
pubmed: 9679818
Kidney Int. 2012 Mar;81(5):442-8
pubmed: 22113526
Kidney Int. 2016 Oct;90(4):853-60
pubmed: 27425855
Nat Immunol. 2010 Oct;11(10):936-44
pubmed: 20729857
J Biol Chem. 2002 Dec 20;277(51):49238-46
pubmed: 12374808
Sci Rep. 2021 Jun 29;11(1):13482
pubmed: 34188068
Cell Rep. 2016 Jul 26;16(4):1082-1095
pubmed: 27425607
Annu Rev Immunol. 2008;26:535-84
pubmed: 18303999
Proc Natl Acad Sci U S A. 2005 Nov 1;102(44):16001-6
pubmed: 16243976
Blood. 2015 May 14;125(20):3118-27
pubmed: 25833963
J Immunol. 2010 Aug 1;185(3):1976-83
pubmed: 20601597
N Engl J Med. 2010 Oct 7;363(15):1451-62
pubmed: 20925547
N Engl J Med. 2013 Jun 20;368(25):2402-14
pubmed: 23782179
Kidney Int. 2012 Sep;82(5):516-24
pubmed: 22673882
PLoS Med. 2006 Nov;3(11):e442
pubmed: 17132052
Nat Rev Nephrol. 2015 Nov;11(11):639-41
pubmed: 26392280
Nat Rev Nephrol. 2019 Mar;15(3):144-158
pubmed: 30692665
J Immunol. 2009 Aug 1;183(3):1598-606
pubmed: 19592658
Clin Cancer Res. 2009 May 1;15(9):2954-61
pubmed: 19383829
Leuk Lymphoma. 2001 Jul;42(3):253-65
pubmed: 11699390
Mol Immunol. 2009 Feb;46(4):613-21
pubmed: 18962896
Cell Rep. 2017 Jun 27;19(13):2756-2770
pubmed: 28658623
Front Immunol. 2022 Sep 15;13:988862
pubmed: 36189261
Mucosal Immunol. 2014 Nov;7(6):1312-25
pubmed: 24670424
J Am Soc Nephrol. 2016 Dec;27(12):3639-3652
pubmed: 27026366
Ann Transplant. 2013 Apr 05;18:153-60
pubmed: 23792515
Nat Immunol. 2006 Jul;7(7):773-82
pubmed: 16767092
Anesthesiology. 2017 Jan;126(1):39-46
pubmed: 27755064
Noncoding RNA. 2018 Dec 18;4(4):
pubmed: 30567388
J Am Soc Nephrol. 2016 Jan;27(1):293-304
pubmed: 26293822
J Exp Med. 2000 Apr 17;191(8):1281-92
pubmed: 10770796
J Am Soc Nephrol. 2011 Aug;22(8):1443-52
pubmed: 21742731
Kidney Int. 2018 Jul;94(1):16-18
pubmed: 29933843
Lancet. 2020 Oct 17;396(10258):1204-1222
pubmed: 33069326
JAMA Netw Open. 2020 Oct 1;3(10):e2019209
pubmed: 33021646
Am J Transplant. 2016 Mar;16(3):808-20
pubmed: 26595644
J Exp Med. 2009 Aug 3;206(8):1803-16
pubmed: 19581408
Circulation. 2003 Oct 28;108(17):2154-69
pubmed: 14581387
Lancet. 2018 Nov 10;392(10159):2052-2090
pubmed: 30340847
Comp Funct Genomics. 2012;2012:564381
pubmed: 22997486
Front Immunol. 2019 Sep 12;10:2191
pubmed: 31572396

Auteurs

Jianling Song (J)

Department of Nephrology, The Second Affiliated Hospital of Nanchang University, Nanchang of Jiangxi, P.R. China.

Ben Ke (B)

Department of Nephrology, The Second Affiliated Hospital of Nanchang University, Nanchang of Jiangxi, P.R. China.

Weiping Tu (W)

Department of Nephrology, The Second Affiliated Hospital of Nanchang University, Nanchang of Jiangxi, P.R. China.

Xiangdong Fang (X)

Department of Nephrology, The Second Affiliated Hospital of Nanchang University, Nanchang of Jiangxi, P.R. China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH